GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » EPS without NRI

U-Neuron Biomedical (ROCO:6973) EPS without NRI : NT$-3.78 (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical EPS without NRI?

U-Neuron Biomedical's earnings per share without non-recurring items for the six months ended in Dec. 2023 was NT$-0.98. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.78.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for U-Neuron Biomedical's EPS without NRI or its related term are showing as below:

ROCO:6973's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 5.15
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

U-Neuron Biomedical's EPS (Diluted) for the six months ended in Dec. 2023 was NT$-0.98. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.78.

U-Neuron Biomedical's EPS (Basic) for the six months ended in Dec. 2023 was NT$-0.98. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.78.


U-Neuron Biomedical EPS without NRI Historical Data

The historical data trend for U-Neuron Biomedical's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical EPS without NRI Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS without NRI
- -0.99 -2.88 -3.42

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI - -1.13 -1.75 -2.80 -0.98

Competitive Comparison of U-Neuron Biomedical's EPS without NRI

For the Biotechnology subindustry, U-Neuron Biomedical's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's PE Ratio without NRI falls into.



U-Neuron Biomedical EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-3.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical  (ROCO:6973) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


U-Neuron Biomedical EPS without NRI Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines